Keyword: Numerof & Associates
In order to grapple with spending increases, the U.S. healthcare industry is transforming the way physicians are compensated.
With the new year, hospitals are officially mandated to post their list prices online for patients to review.
CMS wants drug companies to put their list prices in television ads, but whether that policy is something it can enforce remains a major question.
Some of the largest providers in the U.S. have officially joined forces to launch a nonprofit generic drug company.
CMS allows itself to be caught up in politics while remaining seemingly oblivious to their impact on prospects for change.
Three years ago, almost 60% of healthcare executives predicted they'd be prepared to take on more risk. Just 21% followed through by 2017.
The healthcare industry—and more specifically, the ACA exchanges—would do well to learn from the success of the Medicare Advantage program.
The recent postponement of updates to the CMS Star Rating system is a step in the wrong direction for the healthcare sector.
Payer organizations must carefully select the provider partners with which they want to share risk.
Concerns that the Trump administration may back away from bundled payment models seem to be justified.